What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?

Int J Ophthalmol. 2022 Sep 18;15(9):1413-1415. doi: 10.18240/ijo.2022.09.01. eCollection 2022.
No abstract available

Publication types

  • Editorial